Picton Mahoney Asset Management’s 10x Genomics TXG Stock Holding History

Picton Mahoney Asset Management’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-650	Closed	-$5K	–	1174
2025 Q1	$5K	Sell	650 -993	-60%	-$12.5K	﹤0.01%	650
2024 Q4	$24K	Buy	1,643 +739	+82%	+$11.7K	﹤0.01%	523
2024 Q3	$21K	Buy	904 +841	+1,335%	+$17.4K	﹤0.01%	470
2024 Q2	$1K	Buy	+63	New	+$1.65K	﹤0.01%	587
2019 Q4	–	Sell	-5,000	Closed	-$251K	–	316
2019 Q3	$251K	Buy	+5,000	New	+$277K	0.02%	171

Other funds holding TXG

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Picton Mahoney Asset Management's TXG Position: Q2 2025 in Review

Picton Mahoney Asset Management sold out of 10x Genomics (TXG) in Q2 2025, closing a stake of 650 shares — an estimated $5K sold.

Picton Mahoney Asset Management first reported a position in TXG in Q3 2019 and held it in 5 quarters. The position peaked at $251K in Q3 2019. 297 funds tracked by Wall St. Rank hold TXG as of Q2 2025.

Picton Mahoney Asset Management reported no remaining 10x Genomics position as of Q2 2025 after selling out during the quarter.
Picton Mahoney Asset Management sold 650 10x Genomics shares in Q2 2025, an estimated $5K.
Picton Mahoney Asset Management first reported a position in 10x Genomics in Q3 2019 and held it in 5 quarters.
Picton Mahoney Asset Management's 10x Genomics position peaked at $251K in Q3 2019.
297 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2025.

Based on Picton Mahoney Asset Management's 13F filing for Q2 2025, filed 12 Aug 2025.